Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study
Clinical trial NCT05327452 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05327452
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2026-12-31
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.